July 2020 Vol 11, No 7

AVBCC COVID-19 Webcast Series
COVID-19: Impact on Telehealth
July 2020 Vol 11, No 7
Telehealth continues to play a critical role in providing healthcare services to patients during the COVID-19 pandemic. In a webcast titled COVID-19: Impact on Telehealth, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, along with a panel of experts, discussed the benefits and ongoing challenges associated with the use of telemedicine and the far-reaching impact of this technology beyond the current crisis.
AVBCC COVID-19 Webcast Series
Washington and COVID-19: The Government Response
July 2020 Vol 11, No 7
The federal government is an active participant in shaping healthcare policy and delivering care. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.
AONN+ Responds to Current Affairs
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
July 2020 Vol 11, No 7
Why Is COVID-19 More Aggressive in Patients with Cancer?
July 2020 Vol 11, No 7
Improving Postoperative Multidisciplinary Care Coordination for Patients with Gliomas
Daniel Zeitouni, Michael P. Catalino, Anqi Zhu, Simon Khagi
July 2020 Vol 11, No 7
The authors advocate for nurse navigation services to guide patients through this challenging time in their lives.
Opdivo-Yervoy First Immunotherapy Combo Approved for First-Line Therapy of Patients with Metastatic NSCLC
July 2020 Vol 11, No 7
ctDNA Biomarker Indicates MRD Positivity and Relapse in NSCLC
July 2020 Vol 11, No 7
The Benefit of Second Opinions – Who Needs Them the Most
Jacques Fontaine, MD
July 2020 Vol 11, No 7
Exploring second opinions allows patients to become more informed and secure in their choice of which treatment to pursue.
Bispecific CAR T-Cells Show Promise in Children, Young Adults with Relapsed B-Cell ALL
July 2020 Vol 11, No 7
Universal CAR T-Cells Look Promising as Therapy for T-Cell ALL
July 2020 Vol 11, No 7
I-SPY 2: Durvalumab/Olaparib/Paclitaxel Combination for Breast Cancer “Graduates” to Phase 3 Study
July 2020 Vol 11, No 7
Triple Combination Improves PFS in BRAF-Positive Melanoma
July 2020 Vol 11, No 7
Community Outreach, Prevention & Early Detection: A New National Committee
July 2020 Vol 11, No 7
Loading More Articles

Results 1 - 13 of 13

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
     
    Continue

  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code
    Go Back
SUBSCRIBE

Contact Us | Editorial Board

© 2009-2021 DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512